GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » Research & Development

Captor Therapeutics (WAR:CTX) Research & Development : zł64.85 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Captor Therapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Captor Therapeutics's Research & Development for the three months ended in Dec. 2023 was zł14.57 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was zł64.85 Mil.

Captor Therapeutics Research & Development Historical Data

The historical data trend for Captor Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Therapeutics Research & Development Chart

Captor Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 19.22 23.57 23.12 44.16 64.85

Captor Therapeutics Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.45 13.45 21.44 15.38 14.57

Captor Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł64.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Captor Therapeutics  (WAR:CTX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Captor Therapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of Captor Therapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Captor Therapeutics (WAR:CTX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » Research & Development
Comparable Companies
WAR:SVE WAR:BIO WAR:MAB WAR:PTG WAR:BCX WAR:MOC WAR:URT WAR:PHR WAR:RDG WAR:PUR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
60Q:Germany
Address
ul. Dunska 11, Wroclaw, POL, 54-427
Website
http://www.captortherapeutics.com
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.

Captor Therapeutics (WAR:CTX) Headlines

No Headlines